Efficacy of Talagarbha Pottali With Amrutaadi Kashayam in Hyperuricaemia

Clinical study on the efficacy of Talagarbha Pottali as add-on therapy with Amrutaadi Kashayam in Hyperuricaemia - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068352

Enrollment

Registered

2024-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Known case of Hyperuricaemia with uric acid level more than 6 gm/dl and less than or equal to 12 gm/dl. 2. Patients willing to comply with the requirements of study. 3. Patients willing to give voluntary informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient with a history of or presence of nephrolithiasis or urolithiasis. 2. Patients with renal or hepatic impairment detected through RFT and LFT. 3. Patients with secondary hyperurecaemia detected through CBC, ESR, BSL.

Design outcomes

Primary

Measure	Time frame
Decrease in the serum uric acid level of patients Administered with the study drugTimepoint: serum uric acid assessment will be done on 0th day and 28th day.	—

Secondary

Measure	Time frame
Decrease in pain of the subjects administered with the study drug i.e Talagarbha Pottali along with Amrutaadi kashayamTimepoint: Pain will be assessed on 0th day and 28th day.	—

Countries

India

Contacts

Public ContactDr Noble TM

Government Ayurveda college,Tripunithuru

drnobletm@gmail.com9400829878

Outcome results